BOULDER, Colo.--(BUSINESS WIRE)--
Array BioPharma Inc. (Nasdaq: ARRY) today announced that its Chief
Executive Officer, Robert E. Conway, will speak at the BIO CEO and
Investor Conference in New York City. The public is welcome to
participate in the conference through a webcast on the Array BioPharma
Event: 11th Annual BIO CEO & Investor Conference
Presenter: Robert E. Conway, Chief Executive Officer, Array BioPharma
Date: Monday, February 9, 2009
Time: 1:45 p.m. Eastern Time
Location: Waldorf Astoria Hotel, New York City
About Array BioPharma
Array BioPharma Inc. is a biopharmaceutical company focused on the
discovery, development and commercialization of targeted small molecule
drugs to treat patients afflicted with cancer, inflammatory diseases,
pain and metabolic diseases. Our proprietary drug development pipeline
includes clinical candidates that are designed to regulate
therapeutically important target proteins and are aimed at significant
unmet medical needs. For more information on Array, please go to www.arraybiopharma.com.
Source: Array BioPharma Inc.
Array BioPharma Inc.
Tricia Haugeto, 303-386-1193